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Abstract 
BACKGROUND: Measles is highly contagious and is caused by the RNA morbillivirus. The best protection is 
active immunisation in early childhood. Without immunisation morbidity and mortality of measles are high. In 
recent years, an increasing number of adult measles has been recognised in Europe. 
CASE REPORTS: We report here on two adult patients – a 40-year-old male and a 55-year-old female – who 
presented with fever, fatigue, cough, coryza, conjunctivitis and maculopapular rash. The suspicion of adult 
measles infection was confirmed by positivity for IgM antibodies against measles virus and reverse-transcriptase 
polymerase chain reaction in blood and urine. Patients were isolated, and the treatment was symptomatic. In the 
younger patient, complete recovery was achieved within two weeks. In the older patient, an acute encephalopathy 
developed after initial improvement characterised by cognitive impairment. 
CONCLUSIONS: In patients presenting with fever and maculopapular rash and fatigue, measles should be 
considered even in adult patients. Early diagnosis with subsequent isolation and registration of patients are 
important measures to prevent local outbreaks of the disease. 
 
 
 
 
 
 
 
Introduction 
 
Measles is caused by infection with 
morbillivirus, which belongs to the paramyxoviridae 
family of single-stranded, negative-sense, non-
segmented RNA viruses. The complete genome 
sequence of measles viruses has been discovered [1].  
Measles belongs among the most contagious 
disorders of humankind with a basic reproduction 
number (R0) of 15 to 18, that translates into 15 to 
people who got infected by a single index patient. 
Almost everybody who is not immunised develops 
measles after two hours in the same room with an 
infected patient [2].  
The incubation time is about 10 days. The 
disease is characterised by fever, followed by cough, 
coryza, and conjunctivitis. After 3 days of fever, the 
measles rash appears with small white Koplik's spots 
on the buccal mucosa [3], [4] and maculopapular 
erythema, which starts on the face and spreads 
quickly to the trunk and the extremities [5]. Common 
complications include pneumonia, diarrhoea, middle 
ear infection, and central nervous system symptoms 
including seizures or encephalitis [6]. The risk of 
severe complication of measles is highest in children 
< 5 years of age and in adults > 20 years of age [7]. 
Immunisation provides protection [8]. The 
vaccine coverage in the general population should be 
as high as 95% to provide herd protection. Currently, 
this has not been realised in many European 
countries. In Germany, the Robert Koch Institute 
registered 727 cases of measles in 2017, translating 
into an incidence of 8.9 per 1 000 000 inhabitants. 
About 40% of registered cases were adults older than 
20 years of age [9]. We report here two recent cases 
of adult measles in Dresden, Germany. 
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Case reports 
 
Case 1 
A 40-year-old male patient presented with 
high fever, fatigue, cough, sore throat, dysgeusia, 
conjunctivitis, and diarrhoea in the emergency 
department of the Municipal Hospital Dresden. About 
three days before, he had developed an erythematous 
rash. He had got a vaccination against measles as a 
child. 
On examination, we observed a non-obese 
patient with severe fatigue. Koplik’s spots were 
missing, but the oral mucosa was erythemic, 
vulnerable and bled easily. He had acute conjunctivitis 
and a generalised maculopapular rash including the 
palmar skin (Figure 1a). 
 
Figure 1: Measles: A) and B) Maculopapular rash. Involvement of 
the palms 
Laboratory findings included 
thrombocytopenia, hyponatraemia, a moderate 
increase of C-reactive protein, and increased 
transaminases. Anti-measles IgM antibodies were 
positive in serum probes. Measles virus-RNA was 
detected from oral mucosa swabs and urine by 
polymerase chain reaction (PCR).  
X-ray of the lungs suggested atypical 
pneumonia.  
The patient was immediately isolated. 
Symptomatic therapy with intravenous infusions to 
correct hyponatraemia, antipyretic therapy with 
metamizole and clarithromycin for pneumonia was 
initialised. The patient achieved complete remission 
within 12 days. 
 
Case 2 
A 55-year-old female patient presented with 
fever, fatigue, arthralgia, muscle pain, dyspnea, 
dysphonia, sore throat, cough in the emergency 
department. On the day before, she developed an 
erythematous rash. 
On examination, we found a patient with a 
generalised maculopapular rash, Koplik’s spots, 
conjunctivitis, and basal pulmonary crepitations (Fig. 
1b). 
Laboratory findings were leukopenia with 2.27 
Gpt/L, lymphopenia (11%), increased plasma cell 
count (3%), thrombocytopenia (115 Gpt/L), 5-fold 
increased transaminases ASAT (2.85 µkat/L) and 
ALAT (2.09 µkat/L), gamma-glutamyl transferase 
10.01 µkat/L (15-fold increase), creatinine kinase 22 
µkat/L (8-fold increase), C-reactive protein 23.4 mg/L. 
Infection serology for influenza, hepatitis B, HIV 1/2, 
and legionella spp. was all negative. Measles IgM-
antibodies were positive. PCR for measles from oral 
swabs and urine were positive. Computerised 
tomography of lungs and brain was unremarkable. 
The patient was immediately isolated. 
Symptomatic treatment was initiated, and clinical 
improvement was rapid. After a couple of days, 
however, the patient developed cognitive dysfunction. 
She became unable to organise her daily activities. 
Eventually, she was unable to dress. She lost 
spontaneous communication but could answer simple 
direct questions. We suspected central nervous 
involvement. The cerebrospinal fluid analysis (CSF) 
revealed normal cell counts, protein concentration, 
and immunoglobulin levels. Measles virus PCR was 
negative. Multiplex PCR film array disclosed no 
meningitis or encephalitis pathogens. Magnetic 
resonance imaging (MRI) of the brain was normal. 
Both electrocardiogram and electroencephalogram 
were normal. The neurologic and psychiatric 
evaluation suggested a chronic encephalopathy. 
Improvement was significantly delayed. Therefore, 
neurological rehabilitation was organised.  
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Discussion  
 
Measles is a highly contagious viral disease 
affecting worldwide about 190 000 patients [6]. In the 
European Economic Area, 1818 measles infections 
were reported between July 2015 to June 2016, 
including 309 cases from Germany [10]. Local 
vaccination gaps caused several local epidemics in 
Berlin, Baden-Würtemberg, and Bavaria. The most 
efficient and feasible intervention to limit measles 
outbreaks is the improvement of vaccination rate in 
the general population [11], [12], [13]. 
Clinical diagnosis of measles can be 
confirmed by laboratory methods such as a positive 
serological test for measles-specific immunoglobulin 
M antibody, isolation of measles virus in culture, or 
detection of measles virus RNA by ribonucleic acid 
reverse transcriptase-PCR [6]. 
There is an increasing number of adults 
affected by measles. Our patients disclosed a clinical 
peculiarity. In the typical case, measles exanthema 
spares palms and soles. Both patients, however, had 
involvement of the palms. 
Patients older than 20 years of age are at risk 
of developing major complications such as subacute 
sclerosing panencephalitis (SSPE), a deadly disease 
due to persistence of measles virus in the central 
nervous system [9]. 
In both patients presented here, fatigue was 
associated with the 3 C’s cough, coryza and 
conjunctivitis plus fever. The first patient was probably 
incompletely vaccinated during childhood. This is, 
however, questionable, since his course was not 
characteristic of modified measles. There were no 
vaccination documents available for both.  
Both patients demonstrated 
thrombocytopenia, the most common haematological 
complication. They also suffered from pneumonia, a 
complication that is a major cause of mortality from 
measles in children [14].  
The second patient developed, after clinical 
improvement, a severe neurologic disability. We do 
not expect SSPE since this disease usually develops 
with a delay of 4 to 10 years after acute infection and 
not within days or weeks. Children of less than 5 
years of age represent the majority of cases [15].  
Our second patient did not suffer from slow 
myoclonic jerks, visual symptoms, or periodic 
complexes on EEG. She had no raised titers of anti-
measles antibodies in cerebrospinal fluid. Another 
possible complication is measles inclusion-body 
encephalitis. Again, we could not identify this 
particular disorder in our patient. Approximately one in 
1000 patients with measles develop primary measles 
encephalitis, typically on day 5 of the rash (range: 1-
14 days) [15]. In the present case, encephalitis was 
excluded by CSF analysis and MRI of the brain. We 
suspect a yet not specified measles-induced acute 
encephalopathy [16]. 
In conclusion, measles is still an important 
viral infection worldwide. Due to vaccination gaps, 
adult-onset measles in industrialised Western 
countries such as Germany is increasing. Early 
recognition, isolation of patients and registration by 
the certified boards help to limit outbreaks. 
Symptomatic treatment is sufficient, but complications 
are common. Improved vaccination programs are 
necessary to protect citizens. 
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